A national pharmacy chain has been fined for ordering a Saskatoon pharmacist to over-bill Indigenous Services Canada for drugs used to treat hepatitis C.
The details of the case against SRX Pharma Inc. are contained in a December 2022 decision by a discipline committee of the Saskatchewan College of Pharmacy Professionals, the province’s regulatory body for pharmacists.
SRx opened its Saskatoon pharmacy location in 2017, under the management of a pharmacist identified in the decision only as “DM.”
DM first raised concerns in December 2017 over SRX’s billing practices in regards to a coverage program operated by Indigenous Services Canada (ISC). He resigned from SRx in January 2018, and filed a formal complaint with the college in February of the same year, alleging SRx was marking up medication prices beyond the maximum set by the province, and that it had altered invoices and falsified costs.
He included screenshots of text messages between him and SRx president Adesh Vora, along with copies of invoices, approval and billing forms.
DM first raised concerns after a patient came into the pharmacy in June 2017 with a prescription for Epclusa, a drug used to treat hepatitis C. He noted a discrepancy between the province’s price for a vial of the medicine and what ISC was billed, and asked SRX president Adesh Vora whether the drug was being properly billed. According to the decision, Vora assured DM all was in...
Published on April 28, 2026 In a determined effort to protect the reputation of one of Africa’s most iconic wildlife destinations, Kenya’s Tourism Regulatory Authority has strongly denied false cl...